Total Payments
$7,068
2024 Payments
$984.62
Companies
22
Transactions
187
Medicare Patients
6,437
Medicare Billing
$639,661
Payment Breakdown by Category
Food & Beverage$5,968 (84.4%)
Consulting$1,000 (14.1%)
Education$99.99 (1.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,968 | 185 | 84.4% |
| Consulting Fee | $1,000 | 1 | 14.1% |
| Education | $99.99 | 1 | 1.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $2,875 | 84 | $0 (2024) |
| Allergan, Inc. | $1,049 | 2 | $0 (2020) |
| Lilly USA, LLC | $599.65 | 20 | $0 (2024) |
| Janssen Biotech, Inc. | $359.73 | 15 | $0 (2022) |
| Janssen Scientific Affairs, LLC | $345.37 | 3 | $0 (2021) |
| E.R. Squibb & Sons, L.L.C. | $337.87 | 6 | $0 (2024) |
| Galderma Laboratories, L.P. | $280.54 | 9 | $0 (2023) |
| Celgene Corporation | $181.83 | 8 | $0 (2019) |
| Incyte Corporation | $178.43 | 8 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $142.12 | 3 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $984.62 | 26 | ABBVIE INC. ($395.79) |
| 2023 | $616.13 | 16 | ABBVIE INC. ($245.39) |
| 2022 | $1,285 | 46 | ABBVIE INC. ($765.64) |
| 2021 | $823.93 | 27 | AbbVie Inc. ($300.32) |
| 2020 | $1,348 | 8 | Allergan, Inc. ($1,000) |
| 2019 | $859.82 | 23 | AbbVie, Inc. ($509.14) |
| 2018 | $496.02 | 13 | AbbVie, Inc. ($262.72) |
| 2017 | $654.96 | 28 | AbbVie, Inc. ($257.67) |
All Payment Transactions
187 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $34.47 | General |
| Category: IMMUNOLOGY | ||||||
| 12/02/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $7.11 | General |
| Category: IMMUNOLOGY | ||||||
| 11/14/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $21.50 | General |
| Category: Dermatology | ||||||
| 11/01/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $14.62 | General |
| Category: Inflammation | ||||||
| 10/31/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $30.22 | General |
| Category: IMMUNOLOGY | ||||||
| 10/30/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $22.45 | General |
| Category: Dermatology | ||||||
| 10/25/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $108.75 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/24/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $27.46 | General |
| Category: Immunology | ||||||
| 10/21/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $29.82 | General |
| Category: Dermatology | ||||||
| 09/18/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $112.19 | General |
| Category: IMMUNOLOGY | ||||||
| 08/20/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $16.24 | General |
| Category: IMMUNOLOGY | ||||||
| 07/17/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Winlevi (Drug) | Food and Beverage | In-kind items and services | $46.07 | General |
| Category: Dermatology | ||||||
| 07/11/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $4.14 | General |
| 06/28/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $32.15 | General |
| Category: IMMUNOLOGY | ||||||
| 06/05/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $22.52 | General |
| Category: IMMUNOLOGY | ||||||
| 05/09/2024 | Lilly USA, LLC | OLUMIANT (Drug) | Food and Beverage | In-kind items and services | $29.19 | General |
| Category: Immunology | ||||||
| 04/26/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $29.21 | General |
| Category: Dermatology | ||||||
| 04/18/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $23.92 | General |
| Category: IMMUNOLOGY | ||||||
| 04/04/2024 | Lilly USA, LLC | TALTZ (Drug), OLUMIANT | Food and Beverage | In-kind items and services | $32.02 | General |
| Category: Immunology | ||||||
| 03/14/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $103.08 | General |
| Category: IMMUNOLOGY | ||||||
| 02/29/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $23.71 | General |
| Category: DERMATOLOGY | ||||||
| 02/08/2024 | PFIZER INC. | LITFULO (Drug) | Food and Beverage | In-kind items and services | $43.00 | General |
| Category: IMMUNOLOGY | ||||||
| 02/01/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $113.27 | General |
| Category: Immunology | ||||||
| 02/01/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $21.13 | General |
| Category: Dermatology | ||||||
| 01/18/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $9.75 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 20 | 1,854 | 2,546 | $607,459 | $195,783 |
| 2022 | 19 | 1,561 | 2,108 | $485,357 | $159,178 |
| 2021 | 16 | 1,498 | 1,913 | $442,330 | $151,423 |
| 2020 | 15 | 1,524 | 1,900 | $416,059 | $133,276 |
Total Patients
6,437
Total Services
8,467
Medicare Billing
$639,661
Procedure Codes
70
All Medicare Procedures & Services
70 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 541 | 664 | $139,440 | $45,700 | 32.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 274 | 343 | $102,900 | $34,401 | 33.4% |
| 96920 | Treatment of inflammatory skin disease using laser, less than 250.0 sq cm | Office | 2023 | 22 | 165 | $66,000 | $23,008 | 34.9% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 180 | 216 | $66,096 | $19,773 | 29.9% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 166 | 194 | $50,246 | $15,548 | 30.9% |
| 96910 | Therapy procedure using ultraviolet radiation with tar or petroleum jelly application | Office | 2023 | 26 | 111 | $32,634 | $12,147 | 37.2% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 174 | 217 | $38,409 | $9,210 | 24.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 86 | 86 | $22,360 | $6,440 | 28.8% |
| 11301 | Shaving of skin growth of body, arms, or legs, 0.6-1.0 cm | Office | 2023 | 45 | 47 | $14,006 | $5,058 | 36.1% |
| 96921 | Treatment of inflammatory skin disease using laser, 250.0-500.0 sq cm | Office | 2023 | 11 | 28 | $12,292 | $3,996 | 32.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 28 | 28 | $11,116 | $3,779 | 34.0% |
| 17261 | Destruction of cancer skin growth of trunk, arms, or legs, 0.6-1.0 cm | Office | 2023 | 28 | 31 | $10,943 | $3,560 | 32.5% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 17 | 19 | $8,113 | $3,088 | 38.1% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 65 | 68 | $9,520 | $2,979 | 31.3% |
| 11300 | Shaving of skin growth of body, arms, or legs, 0.5 cm or less | Office | 2023 | 29 | 30 | $7,350 | $2,307 | 31.4% |
| 11306 | Shaving of skin growth of scalp, neck, hands, feet, or genitals, 0.6-1.0 cm | Office | 2023 | 13 | 13 | $3,926 | $1,357 | 34.6% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 96 | 214 | $5,136 | $1,314 | 25.6% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 21 | 27 | $4,023 | $1,248 | 31.0% |
| 11900 | Injection into skin growth, 1-7 growths | Office | 2023 | 15 | 21 | $2,877 | $852.56 | 29.6% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 17 | 24 | $72.00 | $18.79 | 26.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 561 | 709 | $146,338 | $49,439 | 33.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 174 | 213 | $63,900 | $20,416 | 31.9% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 158 | 185 | $56,610 | $17,614 | 31.1% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 141 | 157 | $40,663 | $12,693 | 31.2% |
| 96920 | Treatment of inflammatory skin disease using laser, less than 250.0 sq cm | Office | 2022 | 17 | 80 | $32,000 | $11,659 | 36.4% |
About Dr. Alexis Perkins, MD
Dr. Alexis Perkins, MD is a Dermatology healthcare provider based in Concord, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/07/2008. The National Provider Identifier (NPI) number assigned to this provider is 1659547727.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Alexis Perkins, MD has received a total of $7,068 in payments from pharmaceutical and medical device companies, with $984.62 received in 2024. These payments were reported across 187 transactions from 22 companies. The most common payment nature is "Food and Beverage" ($5,968).
As a Medicare-enrolled provider, Perkins has provided services to 6,437 Medicare beneficiaries, totaling 8,467 services with total Medicare billing of $639,661. Data is available for 4 years (2020–2023), covering 70 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatology
- Location Concord, MA
- Active Since 05/07/2008
- Last Updated 07/27/2016
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1659547727
Products in Payments
- RINVOQ (Biological) $1,090
- Humira (Biological) $639.17
- SKYRIZI (Biological) $582.82
- TREMFYA (Drug) $429.75
- TALTZ (Drug) $369.58
- Sotyktu (Drug) $297.89
- Tremfya (Drug) $275.35
- DUPIXENT (Biological) $238.91
- Otezla (Drug) $231.57
- OPZELURA (Drug) $178.43
- HUMIRA (Biological) $168.94
- Winlevi (Drug) $121.94
- Skyrizi (Biological) $118.49
- AKLIEF (Drug) $64.20
- COSENTYX (Biological) $59.56
- EUCRISA (Drug) $57.74
- EPIDUO FORTE (Drug) $54.92
- Cimzia (Drug) $46.76
- DUPIXENT (Drug) $44.23
- Zoryve (Drug) $43.95
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Concord
William Hoover, Md, MD
Dermatology — Payments: $651,837
Dermatology $651,837
Dr. Heather Holahan, Md, MD
Dermatology — Payments: $15,616
Dermatology $15,616
Dr. Dhwani Mehta, Md, MD
Dermatology — Payments: $11,646
Dermatology $11,646
Dr. Lacey Walls, D.o, D.O
Dermatology — Payments: $11,558
Dermatology $11,558
Andrew Kim, Md, MD
Dermatology — Payments: $11,195
Dermatology $11,195
Nava Greenfield, Md, MD
Dermatology — Payments: $10,175
Dermatology $10,175